ROCÍO
GARCÍA CARBONERO
Profesora titular de universidad
Academic Medical Center
Ámsterdam, HolandaPublicaciones en colaboración con investigadores/as de Academic Medical Center (5)
2023
-
Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer
Cancer Science, Vol. 114, Núm. 3, pp. 1026-1036
2022
-
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
The Lancet Oncology, Vol. 23, Núm. 5, pp. 659-670
2021
-
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial
The Lancet Oncology, Vol. 22, Núm. 5, pp. 665-677
2020
-
Pembrolizumab in microsatellite-instability-high advanced colorectal cancer
New England Journal of Medicine, Vol. 383, Núm. 23, pp. 2207-2218
2018
-
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors
Oncologist, Vol. 23, Núm. 7, pp. 766-e90